The Antifungal Landscape – 1

Some newer azoles are still in development, but most only target candidiasis.  Many years ago we saw development of nikkomycin (Nik Z), a drug mainly for coccidioidomycosis (Valley Fever).  It has no appreciable activity against candida or aspergillus.  Then there is ibrexafungerp, a promising new agent against C. albicans and Continue reading The Antifungal Landscape – 1

Mister S. Goes To Washington

Let’s just assume that Mr. Martin Shkrely had provided full testimony at the Congressional hearing, this is what it might have said: Read my lips: NO MORE REBATES !